the synthesis and storage of RNA and translational products It has been postulated that premature shortening of the (Rossant and Pederson, 1986) which are subsequently used oocyte growth phase due to the recovery of oocytes from for meiotic and early embryonic developmental events (Kastrop small diameter follicles may be responsible for Wickramasinghe and Albertini, 1993 ; Fair developmental anomalies associated with in-vitro matura et al., 1995) .
tion. 6-Dimethylaminopurine (DMAP) was used to artifi-
In vivo, each human menstrual cycle is characterized by the cially lengthen the pre-maturation period of oocyte growth, recruitment and growth of numerous follicles. One or two in vitro, by inhibiting germinal vesicle breakdown in mouse selected follicles continue growth until the day of ovulation, and human oocytes. DMAP inhibited the meiotic maturawhilst most follicles undergo atresia, terminating their growth.
tion of mouse and human oocytes and the inhibition was
By the time of ovulation the dominant follicle measures fully reversible. The timing of polar body extrusion was approximately 20 mmol/l in diameter and may have been accelerated in mouse oocytes following the withdrawal of growing for up to 14 days (Calderon and Healy, 1993 ).
DMAP; however, the kinetics of nuclear maturation in
Human oocytes obtained for in-vitro maturation are aspirated human oocytes was unaffected by exposure to DMAP. All from 2-12 mmol/l antral follicles early in the follicular phase mouse and human DMAP-treated oocytes that matured of the menstrual cycle and are matured for only 48 h in culture. to metaphase II expressed histone H1 kinase activity.
Hence, at the time of aspiration for in-vitro maturation, Fertilization rates in both DMAP-treated and control human oocytes have not fully completed their phase of oocyte mouse and human oocytes were comparable, and human growth and may be retrieved during the process of atresia.
embryonic development was similar in control and
Therefore, all human oocytes retrieved for in-vitro maturation DMAP-treated oocytes. However, blastocyst development have an artificially truncated growth phase. Consequently, it was significantly reduced in DMAP-treated mouse oocytes is possible that the maturational and developmental anomalies (P < 0.05). It is concluded that lengthening the preobserved in in-vitro matured oocytes are attributable to their maturation growth phase, by temporarily inhibiting kinase shortened growth phase and thus the inability to complete activity with DMAP, does not directly improve oocyte all the necessary transcriptional and translational changes developmental competence but provides a useful tool for required for complete maturation and developmental comfurther investigating meiotic and developmentally related petence. Thus, extending the pre-maturation growth phase events in vitro by manipulating meiotic resumption.
in vitro may benefit the embryonic development of in-vitro Key words: 6-dimethylaminopurine/histone H1 kinase/human matured oocytes (Longeran et al., 1997) . Since mammalian oocytes/in-vitro maturation oocytes spontaneously mature upon liberation from the follicle, extending the growth phase requires manipulating the onset of meiotic maturation. The molecular control of meiotic maturation has been extensively studied in a variety of different Introduction species and it is believed to be controlled by M-phase promoting factor (MPF). MPF is a proteinaceous factor in the oocyte Since early seminal work (Pincus and Enzmann, 1935; Edwards, 1965) it has been established that the in-vitro cytoplasm. Purification of MPF has shown that it is composed of p34 cdc2 and cyclin B (Gautier et al., 1988) and in its active maturation of primary oocytes is technically achievable in a variety of different species. Succeeding studies have revealed form this heterodimer has p34 cdc2 kinase activity that may be measured as histone H1 kinase activity (Arion et al., 1988) . that human oocytes can undergo apparently normal nuclear maturation in vitro (Cha et al., 1991; Trounson et al., 1994;  Histone H1 kinase activity is responsible for entry into Mphase and the cascade of events associated with meiotic Barnes et al., 1996; Russell et al., 1997; Wynn et al., 1998) . However, the subsequent embryonic development of in-vitro maturation. 6-Dimethylaminopurine (DMAP), a serine threon-under interference contrast microscopy. Those mouse oocytes with ine protein kinase inhibitor, prevents spontaneous germinal an intact GV were washed several times in fresh culture medium and vesicle breakdown by inhibiting the activation of histone H1 transferred to either histone kinase lysis buffer (Collas et al., 1993) kinase, but does not interfere with protein synthesis (Rime for histone H1 kinase analysis or Laemmli sample buffer (Laemmli, et al., 1989; Fulka et al., 1991 (Rime et al., 1989; Motlík and Kubelka, 1990 ; Fulka maintained in DMAP-supplemented medium for 18 h and subse Szöllösi et al., 1991b) . However, few reports quently examined for the presence of a GV by interference contrast have described the fertilization and embryonic development microscopy.
of oocytes following DMAP treatment.
The medium used for human oocyte culture was Chang's medium (Irvine Scientific, Santa Ana, CA, USA) supplemented with 0.1 IU The present study examined whether DMAP treatment of human recombinant FSH/ml (hr-FSH) (Gonal-F; Serono, Geneva, of immature oocytes could improve subsequent embryonic Switzerland) and 0.1 IU human recombinant luteinizing hormone development. It was postulated that DMAP treatment might (LH)/ml (hr-LH; Serono, Geneva, Switzerland). Directly after aspiraimprove oocyte developmental competence by allowing addition, groups of up to three human OCC were cultured for 24 h in tional transcription and translation to occur in the oocyte Chang's medium supplemented with 2 mmol/l DMAP in 10 µl drops during the extended pre-maturation period.
under light white mineral oil in bacteriological grade sterile Petri dishes (Nunclon, Roskilda, Denmark) at 37°C in humidified 5% CO 2 in air. After 24 h, random samples of human oocytes were collected
Materials and methods
and the adherent cumulus and coronal cells removed as previously Collection of mouse and human oocytes described. Human oocytes were examined for an intact GV or GVBD after first staining with Hoechst 33342 (50 µg/ml; Sigma) for 5 min Immature mouse oocytes were collected from 4-to 6-week old female and examination by interference contrast microscopy and epi-F1 hybrid mice (C57 BL/6 J WEHI femaleϫCBA/CaH WEHI male) fluorescence to confirm interphase chromatin. Those human oocytes using procedures previously described (Anderiesz and Trounson, displaying an intact germinal vesicle were washed in fresh culture 1995) following priming with an intraperitoneal injection of 5 IU medium and transferred to histone kinase lysis buffer for histone H1 pregnant mare's serum gonadotrophin (PMSG, Folligon; Intervet, kinase analysis. Castle Hill, NSW, Australia).
Immature oocytes were also retrieved from 20-day-old pre-pubertal Reversibility of inhibition and kinetics of meiotic maturation F1 female mice that had either received, or not received, priming with 5 IU PMSG 48 h prior to oocyte retrieval. The immature oocytes
The reversibility of meiotic inhibition and the subsequent timing of from the 20-day-old pre-pubertal mice were also retrieved according meiotic maturation of mouse oocytes were examined after 7 h to previously described methods (Anderiesz and Trounson, 1995) .
of culture in DMAP. DMAP-treated mouse oocytes were washed Ovulated metaphase II mouse oocytes were used as controls and thoroughly in α-EMEM and cultured in 20 µl drops of α-EMEM were obtained by administering 5 IU human chorionic gonadotrophin supplemented with 10% FCS and 0.2 IU o-FSH under light white (HCG; Chorulon, Intervet, Castle Hill, NSW, Australia) 48 h after mineral oil for a further 18 h at 37°C in a humidified atmosphere of PMSG. The animals were killed 12-14 h after HCG injection and 5% CO 2 in air. Mouse OCC not exposed to DMAP were used as the mature metaphase II OCC were released from the oviducts into in-vitro matured controls and were concurrently cultured in the α-M2 medium (Quinn et al., 1982) .
EMEM maturation medium supplemented with 10% FCS and 0.2 IU Immature human oocytes were aspirated from the ovaries of women o-FSH for 18 h. Progression of meiotic maturation in both DMAPthat had not received exogenous gonadotrophin stimulation. The treated and untreated oocytes was monitored at 6, 8, 10 and 12 h of details and methods of recovery of human immature oocytes by culture. At these time points, mouse oocytes were randomly selected ultrasound-guided aspiration of 2-12 mmol/l follicles has been and denuded of follicle cells in hyaluronidase solution, as previously described previously (Trounson et al., 1994) .
described. Cumulus denuded oocytes were then placed in a 1% sodium citrate solution for 5 min, transferred to a glass microscope Inhibition of meiotic resumption with DMAP slide, and then fixed using a 3:1 solution of methanol and acetic acid. Oocytes were then stained using 10% Giemsa stain (British Drug The medium used for mouse oocyte culture was Eagle's Minimal Essential Medium -alpha modification (α-EMEM; Sigma, St Louis, House, Kilsyth, Vic, Australia) to visualize the chromosomes and determine the progression of nuclear maturation. Additionally, follow-MO, USA) with 10% fetal calf serum (FCS; Commonwealth Serum Laboratories, Melbourne, VIC, Australia) and 0.2 IU ovine follicle ing the 18 h of in-vitro maturation, random samples of mouse oocytes were denuded of cumulus and coronal cells and examined by stimulating hormone [FSH (o-FSH; Horizon Technology, Roseville, NSW, Australia) ]. Immediately after removal from the interference contrast microscopy for meiotic progression. Those oocytes that had progressed to metaphase II were transferred to either ovarian follicle, groups of up to 15 mouse oocyte cumulus complexes (OCC) were cultured in 20 µl drops of α-EMEM medium supplehistone kinase lysis buffer or Laemmli sample buffer for either histone H1 kinase analysis or the identification of proteins by SDS-PAGE. mented with 2 mmol/l DMAP (Sigma) under light white mineral oil (Sigma) at 37°C in an atmosphere of 5% CO 2 in air for 7 h. The
The reversibility and timing of meiotic maturation in human oocytes exposed to DMAP for 24 h was tested by culturing DMAP treated effect of DMAP on the meiotic inhibition of mouse oocytes was assessed after 3.5 and 7 h. At these time points random samples of oocytes for a further 48 h in vitro. Human OCC not exposed to DMAP were concurrently matured in vitro for 48 h as an in-vitro DMAP-treated mouse oocytes were collected and placed in M2 medium containing 40 IU hyaluronidase (type IV-S, Sigma) and matured control. DMAP treated and control human oocytes were thoroughly washed in Chang's medium and transferred to 10 µl the cumulus and corona radiata cells were removed by gentle micropipetting. Mouse oocytes were examined for an intact germinal Chang's medium supplemented with 0.1 IU hr-FSH and 0.1 IU hr-LH. Oocytes were cultured at 37°C in a humidified atmosphere of vesicle (GV) or indications of germinal vesicle breakdown (GVBD) 5% CO 2 in air under mineral oil. Oocytes were examined for the Immunoblotting and immunodetection of cyclin B and P34 cdc2 presence of a germinal vesicle or extruded first polar body at 24, 30,
Immunoblotting was used to identify the two components of MPF, 36 and 48 h of culture. At the end of 48 h culture, mature metaphase cyclin B and p34 cdc2 . Groups of 30 follicular cell denuded murine II oocytes were denuded of all follicle cells in hyaluronidase, as oocytes were collected: (i) immediately after liberation from the previously described and then transferred to histone kinase lysis follicle (GV stage), (ii) after 7 h of DMAP treatment (GV stage), buffer for histone H1 kinase analysis.
(iii) after completion of meiotic maturation in vitro (18 h of culture without DMAP, MII stage), (iv) after completion of meiotic maturation in vitro following 7 h of DMAP exposure (metaphase II stage), and In-vitro fertilization of mouse and human oocytes (v) after ovulation (metaphase II stage, in vivo control). In addition, Mouse oocytes were fertilized in vitro (IVF) using spermatozoa to identify the direct effect of priming on MPF activation, cyclin B retrieved from the cauda epididymis of two mature F1 (C57 BL/6 J and p34 cdc2 were immunodetected in 30 GV stage oocytes retrieved WEHI femaleϫCBA/CaH WEHI male) male mice. The details and from day 20 pre-pubertal mice that had either received, or did not methods of mouse IVF have been previously described by Anderiesz receive, priming with 5 IU PMSG. and Trounson (1995) . Successful fertilization was assessed by the The immunoblotting procedure entailed the solubilization of the appearance of two pronuclei and the extrusion of the second polar groups of 30 murine oocytes in 10 µl of Laemmli sample buffer body 8-10 h after insemination.
followed by one-dimensional SDS gel electrophoresis of oocyte In-vitro matured human oocytes were fertilized by intracytoplasmic proteins (Laemmli, 1970) . Total oocyte proteins were electrosperm microinjection (ICSI) (Ng et al., 1991) . Oocytes were examined phoretically transferred using a tank transfer system (Bio Rad, under interference contrast microscopy, 16-18 h after ICSI, for the Hercules, CA, USA) at 80 V for 1 h. Proteins were transferred to a presence of two pronuclei and the second polar body.
polyvinylidenedifluoride (PVDF) membrane (Immobilon-P; Millipore, Bedford, MA, USA) and the membranes were probed using anti-human Embryonic development following IVF cyclin B1 mouse monoclonal IgG2 b antibody (Upstate Biotechnology, Mouse zygotes were cultured for 96 h in 20 µl drops of M16 (Quinn Lake Placid, NY, USA) for the detection of the cyclin B antigen and antiet al., 1982) supplemented with 4 mg/ml BSA (Pentex crystallized, human cdc2 kinase (PSTAIR) rabbit polyclonal IgG antibody (Upstate Miles, Kankakee, IL, USA) under light white mineral oil in humidified Biotechnology), for the detection of the p34 cdc2 antigen. The membranes 5% CO 2 in air. Development to blastocysts was recorded on day 4
were subsequently washed and incubated with a secondary antibody post-insemination.
conjugated with horseradish peroxidase (HRPO) (Silenus, Hawthorn, Pronuclear human oocytes were cultured in 4-well culture dishes Victoria, Australia) and antigen visualization was performed using (Nunclon) in modified human tubal fluid medium (IVF-50, Scandinavenhanced chemiluminescent Western blotting detection reagents ian IVF Science AB, Gothenburg, Sweden) without somatic cell (Amersham, Buckinghamshire, UK). support for 2 days after ICSI. From day 2 (2-4 cell stage) to day 5/ 6 (blastocyst stage) of culture, embryos were co-cultured on a Determination of mouse oocyte proteins monolayer of Vero cells (Fong et al., 1997) . On the morning of day Mouse oocyte proteins were separated by 1-dimensional SDS-3, the medium was changed to a 1:1 combination of 50% IVF-50 PAGE. Groups of five follicular cell denuded oocytes were collected: and 50% Hatch-50 (Scandinavian IVF Science AB) and 10% patients' immediately after liberation from the follicle, after 3.5 and 7 h of own serum. On the morning of day 4, the medium was changed to DMAP treatment, after meiotic maturation to metaphase II with and 100% Hatch-50 supplemented with 10% patients' own serum, and without prior DMAP exposure and after ovulation (in-vivo control). embryos were cultured for a further 2 days. All cultures were carried
The groups of oocytes were solubilized by boiling for 3 min in 10 µl out at 37°C in sealed humidified chambers with 5% CO 2 , 5% O 2 and Laemmli sample buffer. 90% N 2.
SDS-PAGE was performed using a 12% (w/v) polyacrylamide gel (Laemmli, 1970) . The gels were run at 150 V for 1 h. After electrophoresis the gels were silver stained (Heukeshaven and Dernick, Measurement of histone H1 kinase 1988) and air-dried overnight between two sheets of acetate paper Histone H1 kinase activity in mouse and human oocytes was (Promega, Annandale, NSW, Australia) at room temperature. determined by methods already described (Collas et al., 1993) using reagents from Sigma unless otherwise stated. Briefly, groups of 10 Statistical analyses follicular cell denuded mouse oocytes, or single denuded human Replicate data were analysed for homogeneity and results are presented oocytes, were lysed by repeated freezing in liquid nitrogen then as mean Ϯ SEM. A minimum of three replicates was performed for thawing in a volume of 10 µl of histone kinase lysis buffer [80 mmol/ every test and variability amongst replicates was examined. No l glycerophosphate, 20 mmol/l EGTA, 15 mmol/l MgCl 2 , 1 mmol/l variability amongst replicates existed (χ 2 ϭ 0.235 on 2 d.f). Resumpdithiothreitol (DTT), 10 µg/ml aprotinin, 10 µg/ml leupeptin, 10 µl/ml tion of maturation, progression of germinal vesicle breakdown, and pepstatin and 50 nmol/l cyclic adenosine monophosphate-dependent kinetics of polar body extrusion were analysed using the χ 2 test for protein kinase inhibitor]. The kinase reaction was initiated by the comparisons between DMAP-treated and untreated (control) groups. addition of 2.5 mg/ml histone H1, 0.7 mmol/l ATP and 12.5µ Ci of (γ-P Ͻ 0.05 was accepted as the level of statistical significance. 32 P) ATP (Amersham, Buckinghamshire, UK). The reaction was carried Fertilization and embryonic data were analysed using linear logistic out for 15 min at ambient temperature (20-25°C) and was stopped by regression. Hypotheses were tested using the Log likelihood Ratio the addition of 5 µl of four times concentrated sample buffer (Laemmli, Statistic (LRS) which was χ 2 distributed. 1970). The samples were then boiled for 3 min. Proteins were separated on a 12% polyacrylamide gel (SDS-PAGE) as described (Laemmli, 1970) . Subsequently the gels were exposed to a Fuji phosphor screen
Results
(Fuji Photofilm Co. Ltd, Japan) overnight at room temperature. Histone
Inhibition of meiotic resumption with DMAP
H1 kinase activity was assessed by scanning the screen using a Fuji Bas Following liberation from the ovarian follicle and culture for 1000 Phosphorimage analyser using Fuji Bio-imager analyser MacBas Version 2.X software.
6 h in vitro, 31/31 mouse oocytes spontaneously progressed oocytes (χ 2 ϭ 1.86). However, the proportion of oocytes having completed meiotic maturation after 18 h of culture was the same in DMAP treated (97%, n ϭ 164) and control oocytes to GVBD. The addition of 2 mmol/l DMAP to the maturation (95%, n ϭ 191). medium was effective in maintaining 91% (n ϭ 189) of mouse
The proportion of DMAP-treated human oocytes that comoocytes at the GV stage for 7 h of culture. Following 18 h of pleted meiotic maturation after withdrawal of DMAP was culture in DMAP 94% (n ϭ 118) mouse oocytes contained an similar to that of in-vitro matured controls (Table I) . Furtherintact GV, confirming the persistence of DMAP inhibition. more, the kinetics of polar body extrusion was similar in Examination of the nucleus of mouse oocytes by fluorescent DMAP treated and untreated human oocytes (Table II) . Thus, microscopy revealed patches of condensed chromatin within DMAP can temporarily inhibit mouse and human meiotic the GV before and after 7 h of DMAP treatment. maturation without effecting subsequent maturation to metaAfter 24 h culture, 81% of immature human oocytes are phase II. known to progress to GVBD (Trounson et al., 1994 (Trounson et al., , 1998 . The presence of 2 mmol/l DMAP effectively inhibited GVBD In-vitro fertilization of mouse and human oocytes in 83% (n ϭ 12) of human oocytes over a 24-h culture period
The presence of two pronuclei and the extrusion of the second (Table I) . polar body determined successful fertilization of both mouse Reversibility of inhibition and kinetics of meiotic maturation and human oocytes. The fertilization rate of in-vivo matured mouse oocytes (in-vivo control) was 90% (n ϭ 127), compared The progression of GVBD occurred more slowly in mouse to 91% (n ϭ 137) for untreated in-vitro matured oocytes (inoocytes following the withdrawal of DMAP with significantly vitro matured controls). This was not significantly different to more (χ 2 ϭ 17.01, P Ͻ 0.001) DMAP treated oocytes (85%) the fertilization rate of mouse oocytes previously exposed to displaying an intact GV after 1 h of culture than control DMAP (91%, n ϭ 127). untreated oocytes (60%). However, by 3 h, GVBD occurred There was no significant difference between the fertilization in 87% (n ϭ 101) of mouse oocytes after the removal of rates for human oocytes after withdrawal of DMAP (77%) DMAP from the culture medium and this was not different to and control, untreated oocytes (75%) ( Table I) . Hence the the number of oocytes undergoing spontaneous GVBD in the temporary inhibition of germinal vesicle breakdown with control, untreated group [88% (n ϭ 120)] by 3 h (Figure 1) . DMAP had no effect on the ability of human or mouse oocytes Eight hours after withdrawal of DMAP treatment, 11% (n ϭ 23) of mouse oocytes were at metaphase II. In to successfully fertilize in vitro. Embryonic development inhibition in the presence of DMAP the histone H1 kinase activity persisted (Figure 2a ). Following withdrawal of DMAP Embryonic development was assessed in mouse oocytes over and maturation to metaphase II, DMAP-treated mouse oocytes a 4-day culture period post-insemination. The development of expressed histone H1 kinase activity, as did the untreated embryos to blastocysts was used as an indicator of developcontrol in-vitro matured oocytes and in-vivo matured mouse mental competence. Development to blastocyst was significoocytes ( Figure 2b ). Figure 2c shows the activation of histone antly higher (P Ͻ 0.001) when mouse oocytes were matured H1 kinase activity in GV stage mouse oocytes, retrieved from in vivo (65%, n ϭ 114) than in vitro (19%, n ϭ 118).
pre-pubertal F1 female mice, following priming with PMSG. Furthermore, the temporary inhibition of the resumption of The expression of histone H1 kinase activity in immature meiosis with DMAP resulted in a significant reduction (P ϭ germinal vesicle stage human oocytes was variable and related 0.002) in development to the blastocyst stage in culture (6%, to the patient. Upon recovery, all the germinal vesicle stage n ϭ 108).
oocytes of patients 1 and 2 had histone kinase activity ( Figure  Human embryonic developmental competence was assessed 3). Furthermore, this histone H1 kinase activity was not by monitoring cleavage over a 5 day culture period. Table III inactivated in the majority of these oocytes after culture in shows the cell number of DMAP treated and control human DMAP for 24 h (Figure 3 ). Both control and DMAP-treated embryos culture over a 5-day period. There was no apparent oocytes from patients 1 and 2 that matured to metaphase II effect of DMAP treatment on subsequent embryonic cleavage expressed histone H1 kinase activity (Figure 3 ). rate or cell number of in-vitro matured and fertilized oocytes.
Germinal vesicle stage oocytes collected from a third patient Histone H1 kinase assay displayed no kinase activity upon recovery (Figure 4 ) and histone H1 kinase activity did not appear during the 24 h GV stage mouse oocytes, retrieved from 4-6 week old female period of exposure to DMAP. After withdrawal of DMAP F1 mice, after priming with PMSG displayed histone H1 kinase activity (Figure 2a) . During the period of meiotic 50% (4/8) of oocytes matured to metaphase II. Histone H1 kinase activity was observed in all the DMAP treated metaphase were identified by immunoblotting and immunodetection techniques. Figure 5a illustrates the presence of p34 cdc2 in II stage oocytes from this patient. A similar proportion of untreated control oocytes, from patient 3, matured to metaphase mouse GV and metaphase II stage oocytes, collected from 4-6-week-old F1 female mice, treated with and without DMAP. II (50%). Interestingly, however, 1/3 of the in-vitro matured control untreated oocytes from this patient that matured to
In its most dephosphorylated and active form, p34 cdc2 can be seen in both GV oocytes collected directly from the ovary and metaphase II showed no histone H1 kinase activity (Figure 4) . GV oocytes exposed to 3.5 h and 7 h of DMAP treatment. In Immunoblotting and immunodetection of cyclin B and P34 cdc2 addition, both DMAP treated and untreated control oocytes that matured to metaphase II along with in-vivo derived To confirm the presence of histone H1 kinase activity in oocytes the composite proteins of MPF, cyclin B and p34 cdc2 , metaphase II controls express p34 cdc2 in its most dephos- Figure 6 . Immunodetection of cyclin B and p34 cdc2 antigens in mouse oocytes exposed (ϩPMSG) or not exposed (-PMSG) to priming with pregnant mare's serum gonadotrophin in vivo. Oocytes were retrieved from 20-day-old mice.
Discussion
Extending the prematuration growth phase in vitro entails inhibiting the onset of meiotic maturation. Pharmacological agents such as cycloheximide, dibutyryl cAMP, IBMX and 6-DMAP have been used to temporarily inhibit the resumption of maturation (Sirard and First, 1988; Rime et al., 1989; Downs, 1990; Motlík and Rimkericová, 1990; Fulka et al., 1991; Kastrop et al., 1991; Mattioli et al., 1991; Szöllösi et al., 1991a; Haider and Chaube, 1996) and lengthen the prematuration period of oocyte growth (Longeran et al., 1997) . Cycloheximide is a protein synthesis inhibitor and exerts its effect on oocyte maturation by preventing the synthesis of proteins that participate in meiotic resumption. Membranepermeable cAMP analogues, such as dibutyryl cAMP and triggers MPF activity and cell cycle progression (Jessus et al., h of DMAP treatment; Lane G, in-vivo matured MII stage oocytes.
1991). Ooplasmic protein synthesis is an extremely important
Each lane contains five follicular cell denuded mouse oocytes.
function that confers oocyte meiotic and developmental competence. cAMP is equally important as it mediates many second messenger pathways and is directly involved in mediating the phorylated state. Figure 5b demonstrates the presence of cyclin hormonal actions of gonadotrophins (Segaloff and Ascoli, B in both GV and metaphase II stage DMAP treated and 1993). The actions of gonadotrophins, in turn, influence oocyte untreated control mouse oocytes. maturation (Süss et al., 1988) follicular cell steroidogenesis The immature oocytes from 20-day-old, non-cycling, female (Segaloff and Ascoli, 1993) , protein synthetic capacity of the F1 hybrid mice were used to investigate the effect of priming oocyte (Moor et al., 1985) , and developmental competence with PMSG on p34 cdc2 and cyclin B content. Figure 6 shows (Moor and Trounson, 1977) . The present study served to a large increase in cyclin B and the concomitant expression investigate whether oocyte developmental competence could of p34 cdc2 in its dephosphorylated form following PMSG be improved by extending the pre-maturation period of oocyte administration.
growth. Therefore, due to the direct involvement of protein Mouse oocyte proteins synthesis and cAMP in the regulation of developmental competence, pharmacological agents such as cycloheximide, The profile of oocyte proteins changes as oocytes mature.
IBMX, and dibutyryl cAMP were not used for the current Figure 7 illustrates the protein profiles of DMAP treated and experiments. untreated oocytes at both the GV and metaphase II stage.
The ability to reversibly inhibit meiotic maturation in human Detailed observation shows no apparent variations in cytooocytes has never previously been reported. These findings plasmic proteins between DMAP treated and untreated oocytes at either the GV stage or metaphase II stage.
demonstrate that concentrations effective at preventing meiotic resumption in other species (Motlík and Rimkevicová, 1990 ; of its two major residues, tyrosine 14 and threonine 15, by a cdc 25 phosphatase (Maller, 1994) . Histone H1 kinase activity Fulka et al., 1991) effectively prevent GVBD in 83% of human oocytes for 24 h. The temporary inhibition of nuclear has previously been shown to exist in GV stage porcine and murine oocytes (Naito and Toyoda, 1991; Choi et al., 1991 ; maturation was fully reversible and DMAP-treated human oocytes matured to metaphase II in the same numbers and Naito et al., 1992; Christmann et al., 1994; Gavin et al., 1994) . Therefore, histone H1 kinase activity can be detected in the with the same maturation kinetics as non-treated oocytes.
Similarly, 2 mmol/l DMAP was shown to be capable of cytoplasm of oocytes prior to the breakdown of the GV, and then increases to high concentrations at metaphase I. The preventing meiotic maturation in mouse oocytes, confirming previous reports (Rime et al., 1989; Szöllösi et al., 1991b) activity decreases during anaphase and telophase and increases again to a high concentration at metaphase II (Doree et al. , and subsequent maturation to metaphase II, after 18 h, was similar in DMAP-treated and untreated oocytes. Interestingly, 1983; Gerhart et al., 1984) . In the current study, histone H1 kinase activity was present in mouse GV stage oocytes retrieved the kinetics of meiotic resumption was altered in the DMAPtreated oocytes. Proteins with a rapid turnover rate are involved directly from the ovaries of PMSG-treated mice and the kinase activity was maintained in the GV stage oocytes for the in the spontaneous maturation of rodent oocytes (Downs, 1990) and, during prolonged periods of meiotic arrest, these duration of DMAP treatment. Immunodetection of cyclin B and p34 cdc2 in GV stage DMAP-treated and freshly isolated short-lived proteins are degraded (Ekholm and Magnusson, 1979) . Furthermore, other studies (Motlík and Rimkevicová, control, PMSG primed mouse oocytes revealed the presence of both cyclin B and p34 cdc2 . Furthermore, p34 cdc2 was present 1990) demonstrated that mouse oocytes preincubated with DMAP require active protein synthesis for the resumption of in its most dephosphorylated and active form, confirming the existence of histone H1 kinase activity in this population of GVBD. Thus, the time taken for the resynthesis of proteins required for GVBD may be responsible for the slower resumpoocytes. The observation of premature chromosome condensation is also consistent with the presence of histone H1 kinase tion of meiotic maturation observed in DMAP treated oocytes.
Although meiotic resumption to the GVBD stage occurs activity and has been previously observed in DMAP-treated oocytes (Szöllösi et al., 1991b) . Priming with PMSG appears spontaneously in rodent oocytes in vitro, the meiotic progression of oocytes from the GVBD to the metaphase II stage to be responsible for activating histone H1 kinase activity in GV stage oocytes, as evidenced from the appearance of histone requires active protein synthesis (Shultz and Wassarman, 1977; Downs, 1990) . In the presence of DMAP, translationary activity H1 kinase activity, increased concentrations of cyclin B, and the stimulated generation of p34 cdc2 in its dephosphorylated continues in mouse oocytes (Rime et al., 1989) . Consequently, proteins required for the completion of meiotic maturation and active form in the GV oocytes of pre-pubertal mice. Interestingly, GV stage mouse oocytes that expressed histone may be synthesized and stored in the ooplasm during DMAP treatment. In addition, the acceleration of morphological events H1 kinase activity did not undergo subsequent meiotic maturation. It has been suggested (de Vantéry et al. 1996 ) that a such as chromatin condensation and microtubule formation following DMAP treatment has been previously demonstrated critical threshold concentration of p34 cdc2 has to be reached for meiotic maturation to be spontaneously triggered. Thus, in activated mouse oocytes (Szöllösi et al., 1993) and was attributable to the inhibition of specific kinases (Moreno and the inability of these mouse oocytes to undergo GVBD may be due to sub-threshold concentrations of p34 cdc2 . Nurse, 1990) . Thus, the immediate utilization of translated and stored proteins together with kinase inhibition may account Interestingly, at the time of retrieval, GV stage oocytes from patients 1 and 2 exhibited histone H1 kinase activity. Histone for the acceleration of meiotic progression from GVBD to metaphase II observed in DMAP-treated mouse oocytes.
H1 kinase activity was not expected in the GV stage oocytes as these populations of oocytes were retrieved from women The failure of human oocytes to display accelerated maturation kinetics may be due to the inability of oocytes to generate that were not exposed to any exogenous gonadotrophin treatment prior to oocyte aspiration. Oocyte aspiration is a and accumulate all the proteins required for meiotic maturation during the 24-h period of meiotic inhibition with DMAP. That non-selective retrieval process that results in the collection of oocytes from the entire cohort of follicles. Considering that is, a longer period may be required by human oocytes to translate all the proteins required for meiotic resumption and only one follicle reaches dominance during the human menstrual cycle, whilst the other follicles become atretic, the progression.
Histone H1 kinase activity was qualitatively assessed in majority of oocytes collected from these patients would have been rescued from follicles either destined for or in the process DMAP-treated and control, GV and metaphase II-stage oocytes. Cyclin B and p34 cdc2 , the two components of MPF, exist in a of follicular atresia. Whilst incapable of supporting complete nuclear maturation (Gougeon and Testart, 1986) , follicular dimerized, fully phosphorylated and non-active form in the cytoplasm of growing oocytes as pre-MPF (Gautier and Maller, atresia has been implicated in modifying GV chromatin and eliciting the resumption of meiotic maturation in oocytes 1991; Christmann et al., 1994) . However, the association of p34 cdc2 with cyclin B is insufficient for activation of kinase (Lefevre et al., 1989) . The maturational changes associated with atresia are believed to be due, in part, to a decline or activity (Jeffrey et al., 1995) . The activation of H1 kinase activity is associated with the p34 cdc2 component of the MPF removal of inhibitory factors (Channing et al., 1982; Gougeon and Testart, 1986) resulting from atresia related follicular cell heterodimer (Choi et al., 1991; de Vantéry et al., 1996) and the activation of kinase activity is dependent on the association death (Channing et al., 1982) . Since all the oocytes assessed from patients 1 and 2 were homogeneous in their expression of p34 cdc2 with cyclin B and the subsequent dephosphorylation of histone H1 kinase activity, at the time of oocyte retrieval, (Rime et al., 1989; Szöllösi et al., 1991b) . Cell cycle progression involves cyclin degradation and this occurs by a ubiquitinit is possible that these oocytes were derived from follicular cohorts in the process of atresia. Consequently, the kinase dependent pathway requiring intact microtubules (Glotzer et al., 1991; Kubiak et al., 1993) . It is therefore possible that activity would be due to follicular atresia.
In contrast, the consistent lack of kinase activity in the the reduced development to blastocyst is attributable to slowing and eventual cessation of cell cycle progression due to inhibited freshly aspirated oocytes from patient 3 may be due to the retrieval of oocytes from a cohort of viable, growing follicles, cyclin degradation. Artificially extending the prematuration period with DMAP prior to the onset of atretic changes.
In keeping with previous findings (Rime et al., 1989;  neither positively nor negatively effected either the fertilization or early cleavage of human embryos. The developmental Szöllösi et al., 1993) we have reported that once histone H1 kinase activity is present, DMAP is unable to inactivate the retardation and blockage of human embryos in the present experiments was similar to that observed for oocytes under a histone H1 kinase activity. The inability of DMAP to inactivate the active kinase activity is attributable to the prevention of wide range of conditions in vitro (Barnes et al., 1996; Trounson et al., 1996 Trounson et al., , 1998 . It is evident that in-vitro matured human cyclin degradation and the protection of the cdc2 kinase from inactivation (Felix et al., 1990) . However, in the presence of oocytes are developmentally compromised and the nature of the developmental deficiencies is still speculative. Despite the MPF activity, DMAP prevented the germinal vesicle breakdown and progression of meiotic maturation. Hunt proposed lack of improvement in embryonic development following DMAP exposure, the extension of the prematuration period of that, once activated by dephosphorylation, the kinase activity of p34 cdc2 could control its own subsequent dephosphorylation, oocyte growth may still represent a feasible technique for the improvement of embryonic developmental competence. leading to the auto-amplification of MPF (Hunt, 1989) . Furthermore, it has been suggested that DMAP prevents the autoHowever, a more specific or physiological meiotic inhibitor would be required. amplification of MPF (Jessus et al., 1991) . Thus, the inhibition of complete meiotic maturation by DMAP in the presence of
The results of this study demonstrate for the first time that it is possible to reversibly inhibit meiotic maturation in human histone H1 kinase activity may be due to the prevention of auto-amplification of MPF.
oocytes with DMAP with no apparent effect on embryonic development. Furthermore, the ability to regulate human oocyte In comparison, if histone H1 kinase activity is not present in the oocyte, DMAP can successfully prevent the appearance maturation provides us with a powerful tool to further investigate the mechanisms of human oocyte maturation and the of the kinase by preventing the dephosphorylation of p34 cdc2 (Jessus et al., 1991) for the duration of DMAP exposure. acquisition of developmental competence. All the DMAP-treated human and mouse oocytes that matured to metaphase II expressed histone H1 kinase activity,
